Basic Information
Basic information for LINC00343-220-15aa-1
Peptide Name LINC00343-220-15aa-1
Genome Position chr13:105706897-105706917,105707100-105707123[+]
Species Human
Peptide Sequence MGKKPGKYPWLCTFE
Peptide Length 15
Unique No (LINC00343-203-15aa,LINC00343-214-15aa-1,LINC00343-215-15aa,LINC00343-221-15aa-1,LINC00343-224-15aa,LINC00343-228-15aa-2,LINC00343-234-15aa-1,LINC00343-235-15aa-1,LINC00343-237-15aa-2,LINC00343-239-15aa-1,LINC00343-242-15aa-1,LINC00343-243-15aa-2,LINC00343-245-15aa-1,LINC00343-246-15aa,LINC00343-248-15aa,LINC00343-249-15aa-1,LINC00343-250-15aa-2,LINC00343-251-15aa,LINC00343-252-15aa,LINC00343-253-15aa,LINC00343-255-15aa,LINC00343-256-15aa-1,LINC00343-257-15aa,LINC00343-259-15aa-1,LINC00343-262-15aa,LINC00343-264-15aa,LINC00343-265-15aa-1,LINC00343-266-15aa,LINC00343-268-15aa,LINC00343-269-15aa-1,LINC00343-270-15aa-2,LINC00343-273-15aa-2,LINC00343-274-15aa-1,LINC00343-275-15aa,LINC00343-277-15aa,LINC00343-278-15aa-2,LINC00343-280-15aa-1,LINC00343-281-15aa,LINC00343-283-15aa-1,LINC00343-284-15aa,LINC00343-285-15aa-1,LINC00343-287-15aa-1,LINC00343-291-15aa,LINC00343-293-15aa,LINC00343-305-15aa,LINC00343-306-15aa,LINC00343-307-15aa,LINC00343-308-15aa,LINC00343-309-15aa-2,LINC00343-312-15aa-2,LINC00343-316-15aa-2,LINC00343-318-15aa,LINC00343-319-15aa-1,LINC00343-323-15aa,LINC00343-324-15aa,LINC00343-325-15aa,LINC00343-328-15aa-2)
Grand Average of Hydropathicity -0.74
Relative Molecular Mass 2037.4
Experimental Evidences no
lncRNA ID/Name ENSG00000226620;LINC00343
Transcript ID/Name ENST00000654904;LINC00343-220
Transcript Length 1308
Coding Ability 0.5642
DNA Sequence Corresponding to Peptide ATGGGAAAGAAACCTGGAAAGTACCCTTGGCTGTGTACATTTGAG
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :